Form 4 for ARDX ARDELYX, INC.
Accepted 2024-01-18 00:00:00 ET · period of report 2024-01-16 · accession 0001628280-24-001692 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-18 | 2024-01-16 | ARDX | Williams Laura A | Chief Medical Off | A - Grant | $0.00 | +118.8K | 384.9K | +45% | $0 |
| D | 2024-01-18 | 2024-01-16 | ARDX | Williams Laura A | Chief Medical Off | A - Grant | $0.00 | +152.1K | 152.1K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-16 | A | A | 118,750 | $0.00 | 384,941 | D | — | — | (F1) Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof. |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-01-16 | A | A | 152,127 | $0.00 | 152,127 | D | $8.78 · — to 2034-01-16 | 152,127 Common Stock | (F2) The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 16, 2024, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. |